Deadline for Medtech Innovator Applications is January 31, 2023
- No Comments
Applications for three different Innovator programs – MedTech Innovator US, MedTech Innovator Asia Pacific, and BioTools Innovator – are now open. Numerous LaunchPort Residents have been selected for participation in Medtech Innovators in the past, and this excellent program provides access to mentors and high visibility at the annual Medtech Conference each Fall. See details from Medtech Innovators below:
MedTech Innovator 2023 Accelerator for Seed-Series C Companies
Apply Now for Our 2023 Programs!
Applications for our three different Innovator programs – MedTech Innovator US, MedTech Innovator Asia Pacific, and BioTools Innovator – are now open. Read below to learn which program is right for you and apply today.
Companies do not have to relocate, and there is no equity required or fee for participation. The application deadline for all programs is January 31, 2023.
Our flagship program, MedTech Innovator, is intended to support all early and mid-stage medical device, diagnostic, and digital health companies. Benefits of the program include: high profile visibility to healthcare investors and decision makers, access to a best-in-class network of mentors and peers, and participation in a customized virtual curriculum. Accelerator companies will have the opportunity to be mentored by our corporate partners such as Asahi Intecc, BD, Dexcom, Edwards Lifesciences, Fujikura, Jabil Healthcare, Johnson & Johnson, Maxim Integrated Ventures, Olympus, NIPRO, W.L. Gore & Associates, RCT Ventures and many other industry leaders. Additionally, there’s a chance to compete for up to $500,000 in non-dilutive cash prizes and in-kind awards! For more information visit our Apply Page.
MedTech Innovator US Informational Webinar | Dec 1 @ 10am PST
Register here
If you are a medtech company interested in entering the Asia Pacific market, then the MedTech Innovator Asia Pacific program is made for you. This program runs in parallel with the US program and offers many of the same benefits—high-profile visibility, access to industry decision-makers, and a customized curriculum including 1-1 corporate mentorship—and is specifically intended to support companies developing their market access strategies for the Asia Pacific region. Additionally, there’s a chance to compete for up to $300,000 in non-dilutive cash prizes and in-kind awards! For more information visit our Apply Page.
MedTech Innovator APAC Informational Webinar | Jan 15 @ 6pm PST / Jan 16 @ 10am SGT Register here
MedTech Innovator APAC Informational Webinar, S. Korea | Jan 16 @ 5pm PST / Jan 17 @ 9am SGT
We’re thrilled to announce the launch of the 3rd cycle of BioTools Innovator, our newest accelerator program intended to advance life science tools innovation and improve human health. BioTools Innovator is supported by two of the leading investment groups in the space, Research Corporation Technologies and BroadOak Capital Partners.
Companies selected for this honor receive a slot in the BioTools Innovator Accelerator, which provides high profile visibility and access to investors, stakeholders, decision makers; a network of mentors and peers; and participation in a customized educational curriculum. Additionally, accelerator companies compete for up to $300,000 in non-dilutive funding. Acceptance into the BioTools Innovator Accelerator is based on the stage of the startup, with preference for companies that have not yet raised a Series B or established a significant strategic partnership. For more information visit our Apply Page.
BioTools Innovator Informational Webinar | Dec 7 @ 9am PST
Register here
